{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:04:48Z","timestamp":1791288288301,"version":"4.3.0"},"reference-count":111,"publisher":"Impact Journals, LLC","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,4,5]]},"DOI":"10.18632\/oncotarget.7967","type":"journal-article","created":{"date-parts":[[2016,3,11]],"date-time":"2016-03-11T21:43:51Z","timestamp":1457732631000},"page":"18999-19017","source":"Crossref","is-referenced-by-count":33,"title":["EBV reactivation as a target of luteolin to repress NPC tumorigenesis"],"prefix":"10.18632","volume":"7","author":[{"given":"Chung-Chun","family":"Wu","sequence":"first","affiliation":[{"name":"National Institute of Cancer Research, National Health Research Institutes, Zhunan, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Yeu","family":"Fang","sequence":"additional","affiliation":[{"name":"National Institute of Cancer Research, National Health Research Institutes, Zhunan, Taiwan"},{"name":"Department of Pathology, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Yu","family":"Hsu","sequence":"additional","affiliation":[{"name":"National Institute of Cancer Research, National Health Research Institutes, Zhunan, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin-Ying","family":"Chuang","sequence":"additional","affiliation":[{"name":"National Institute of Cancer Research, National Health Research Institutes, Zhunan, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Jhen","family":"Cheng","sequence":"additional","affiliation":[{"name":"National Institute of Cancer Research, National Health Research Institutes, Zhunan, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Ju","family":"Chen","sequence":"additional","affiliation":[{"name":"National Institute of Cancer Research, National Health Research Institutes, Zhunan, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Ping","family":"Chou","sequence":"additional","affiliation":[{"name":"National Institute of Cancer Research, National Health Research Institutes, Zhunan, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Yen","family":"Huang","sequence":"additional","affiliation":[{"name":"National Institute of Cancer Research, National Health Research Institutes, Zhunan, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Fang","family":"Lin","sequence":"additional","affiliation":[{"name":"National Institute of Cancer Research, National Health Research Institutes, Zhunan, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Chang","sequence":"additional","affiliation":[{"name":"National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Tainan, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Hwa","family":"Tsai","sequence":"additional","affiliation":[{"name":"Department of Microbiology, College of Medicine, National Taiwan University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jen-Yang","family":"Chen","sequence":"additional","affiliation":[{"name":"National Institute of Cancer Research, National Health Research Institutes, Zhunan, Taiwan"},{"name":"Department of Microbiology, College of Medicine, National Taiwan University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,3,8]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","article-title":"Global cancer statistics, 2002","volume":"55","author":"Pisani","year":"2005","journal-title":"CA Cancer J Clin"},{"key":"2","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1200\/JCO.1998.16.4.1310","article-title":"Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized intergroup study 0099","volume":"16","author":"Ensley","year":"1998","journal-title":"J Clin Oncol"},{"key":"3","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/sj.bjc.6600716","article-title":"Outpatient weekly neoadjuvant chemotherapy followed by radiotherapy for advanced nasopharyngeal carcinoma: high complete response and low toxicity rates","volume":"88","author":"Wang","year":"2003","journal-title":"Br J Cancer"},{"key":"4","first-page":"565","article-title":"Treatment outcomes for different subgroups of nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapy","volume":"30","author":"Lu","journal-title":"Chin J Cancer"},{"key":"5","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0360-3016(99)00512-X","article-title":"Total biological effect on late reactive tissues following reirradiation for recurrent nasopharyngeal carcinoma","volume":"46","author":"Ho","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"6","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/rmv.1780","article-title":"Switching of EBV cycles between latent and lytic states","volume":"24","author":"Tsurumi","year":"2014","journal-title":"Rev Med Virol"},{"key":"7","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.semcancer.2014.01.002","article-title":"Regulation of the latent-lytic switch in Epstein-Barr virus","volume":"26","author":"Mertz","year":"2014","journal-title":"Semin Cancer Biol"},{"key":"8","first-page":"2575","volume-title":"Field's Virology","author":"Howley","year":"2001"},{"key":"9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/978-1-4684-4163-5","volume-title":"The Herpesviruses I","author":"Roizman","year":"1982"},{"key":"10","first-page":"123","volume-title":"Principles and Practice of Clinical Virology","author":"Schoub","year":"2004"},{"key":"11","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1128\/CMR.1.3.300","article-title":"Epstein-Barr virus and human diseases: recent advances in diagnosis","volume":"1","author":"Purtilo","year":"1988","journal-title":"Clin Microbiol Rev"},{"key":"12","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1093\/oxfordjournals.epirev.a036130","article-title":"Etiology of nasopharyngeal carcinoma: a review","volume":"15","author":"Levine","year":"1993","journal-title":"Epidemiol Rev"},{"key":"13","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1046\/j.1365-2273.2001.00449.x","article-title":"The aetiology of nasopharyngeal carcinoma","volume":"26","author":"Watkinson","year":"2001","journal-title":"Clin Otolaryngol Allied Sci"},{"key":"14","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/2281056a0","article-title":"EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx","volume":"228","author":"Santesson","year":"1970","journal-title":"Nature"},{"key":"15","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1073\/pnas.56.6.1699","article-title":"Precipitating antibody in human serum to an antigen present in cultured burkitt's lymphoma cells","volume":"56","author":"Clifford","year":"1966","journal-title":"Proc Natl Acad Sci U S A"},{"key":"16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijc.2910170102","article-title":"Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma","volume":"17","author":"Henle","year":"1976","journal-title":"Int J Cancer"},{"key":"17","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/jmv.1890270403","article-title":"Antibody to Epstein-Barr virus-specific DNase as a marker for field survey of patients with nasopharyngeal carcinoma in Taiwan","volume":"27","author":"Hwang","year":"1989","journal-title":"J Med Virol"},{"key":"18","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/jmv.1890160202","article-title":"Antibody response to Epstein-Barr-virus-specific DNase in 13 patients with nasopharyngeal carcinoma in Taiwan: a retrospective study","volume":"16","author":"Yang","year":"1985","journal-title":"J Med Virol"},{"key":"19","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1056\/NEJMoa011610","article-title":"Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men","volume":"345","author":"Yang","year":"2001","journal-title":"N Engl J Med"},{"key":"20","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/ijc.2910370508","article-title":"Detection of IgG and IgA antibodies to Epstein-Barr virus membrane antigen in sera from patients with nasopharyngeal carcinoma and from normal individuals","volume":"37","author":"Wolf","year":"1986","journal-title":"Int J Cancer"},{"key":"21","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/sj.bjc.6603609","article-title":"Sustained elevation of Epstein-Barr virus antibody levels preceding clinical onset of nasopharyngeal carcinoma","volume":"96","author":"Ng","year":"2007","journal-title":"Br J Cancer"},{"key":"22","doi-asserted-by":"crossref","first-page":"e19100","DOI":"10.1371\/journal.pone.0019100","article-title":"Fluctuations of Epstein-Barr virus serological antibodies and risk for nasopharyngeal carcinoma: a prospective screening study with a 20-year follow-up","volume":"6","author":"Hong","year":"2011","journal-title":"PLoS One"},{"key":"23","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nrc1452","article-title":"Epstein-Barr virus: 40 years on","volume":"4","author":"Rickinson","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"24","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1038\/sj.onc.1207375","article-title":"Epstein-Barr virus latent membrane protein 1 induces micronucleus formation, represses DNA repair and enhances sensitivity to DNA-damaging agents in human epithelial cells","volume":"23","author":"Chen","year":"2004","journal-title":"Oncogene"},{"key":"25","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1038\/sj.onc.1208319","article-title":"Epstein-Barr virus latent membrane protein 1 represses p53-mediated DNA repair and transcriptional activity","volume":"24","author":"Chen","year":"2005","journal-title":"Oncogene"},{"key":"26","doi-asserted-by":"crossref","first-page":"8124","DOI":"10.1128\/JVI.00430-08","article-title":"Epstein-Barr virus latent membrane protein 1 represses DNA repair through the PI3K\/Akt\/FOXO3a pathway in human epithelial cells","volume":"82","author":"Chen","year":"2008","journal-title":"J Virol"},{"key":"27","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.cancergencyto.2003.09.007","article-title":"Sequential cytogenetic and molecular cytogenetic characterization of an SV40T-immortalized nasopharyngeal cell line transformed by Epstein-Barr virus latent membrane protein-1 gene","volume":"150","author":"Jin","year":"2004","journal-title":"Cancer Genet Cytogenet"},{"key":"28","doi-asserted-by":"crossref","first-page":"6905","DOI":"10.1073\/pnas.121016998","article-title":"Induction of cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells","volume":"98","author":"Pagano","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"29","first-page":"1946","article-title":"Induction of interleukin-8 by Epstein-Barr virus latent membrane protein-1 and its correlation to angiogenesis in nasopharyngeal carcinoma","volume":"7","author":"Furukawa","year":"2001","journal-title":"Clin Cancer Res"},{"key":"30","first-page":"256","article-title":"Regulation of matrix metalloproteinase-1 by Epstein-Barr virus proteins","volume":"63","author":"Tsai","year":"2003","journal-title":"Cancer Res"},{"key":"31","doi-asserted-by":"crossref","first-page":"5223","DOI":"10.1128\/MCB.24.12.5223-5234.2004","article-title":"Epstein-Barr virus latent membrane protein 1 induces synthesis of hypoxia-inducible factor 1 alpha","volume":"24","author":"Pagano","year":"2004","journal-title":"Mol Cell Biol"},{"key":"32","doi-asserted-by":"crossref","first-page":"9870","DOI":"10.1158\/0008-5472.CAN-06-1679","article-title":"EBV latent membrane protein 1 up-regulates hypoxia-inducible factor 1alpha through Siah1-mediated down-regulation of prolyl hydroxylases 1 and 3 in nasopharyngeal epithelial cells","volume":"66","author":"Pagano","year":"2006","journal-title":"Cancer Res"},{"key":"33","doi-asserted-by":"crossref","first-page":"4613","DOI":"10.1038\/onc.2014.66","article-title":"Exosomal HIF1alpha supports invasive potential of nasopharyngeal carcinoma-associated LMP1-positive exosomes","volume":"33","author":"Shackelford","year":"2014","journal-title":"Oncogene"},{"key":"34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2013.05.018","article-title":"Pathogenic role of Epstein-Barr virus latent membrane protein-1 in the development of nasopharyngeal carcinoma","volume":"337","author":"Ito","year":"2013","journal-title":"Cancer Lett"},{"key":"35","doi-asserted-by":"crossref","first-page":"8857","DOI":"10.1128\/JVI.73.10.8857-8866.1999","article-title":"Requirement for cell-to-cell contact in Epstein-Barr virus infection of nasopharyngeal carcinoma cells and keratinocytes","volume":"73","author":"Tsai","year":"1999","journal-title":"J Virol"},{"key":"36","first-page":"713","article-title":"Establishment and characterization of two nasopharyngeal carcinoma cell lines","volume":"62","author":"Chuang","year":"1990","journal-title":"Lab Invest"},{"key":"37","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Weinberg","year":"2011","journal-title":"Cell"},{"key":"38","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1002\/ijc.24179","article-title":"Recurrent chemical reactivations of EBV promotes genome instability and enhances tumor progression of nasopharyngeal carcinoma cells","volume":"124","author":"Chen","year":"2009","journal-title":"Int J Cancer"},{"key":"39","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1093\/nar\/gkp1169","article-title":"Epstein-Barr virus DNase (BGLF5) induces genomic instability in human epithelial cells","volume":"38","author":"Chen","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"40","doi-asserted-by":"crossref","first-page":"e39217","DOI":"10.1371\/journal.pone.0039217","article-title":"Epstein-Barr virus BGLF4 kinase retards cellular S-phase progression and induces chromosomal abnormality","volume":"7","author":"Chen","year":"2012","journal-title":"PLoS One"},{"key":"41","doi-asserted-by":"publisher","first-page":"8583","DOI":"10.18632\/oncotarget.2323","article-title":"Epstein-Barr virus BALF3 mediates genomic instability and progressive malignancy in nasopharyngeal carcinoma","volume":"5","author":"Chen","year":"2014","journal-title":"Oncotarget"},{"key":"42","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.bcp.2006.02.009","article-title":"Molecular targets of dietary agents for prevention and therapy of cancer","volume":"71","author":"Shishodia","year":"2006","journal-title":"Biochem Pharmacol"},{"key":"43","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1126\/science.8160011","article-title":"Diet and health: what should we eat?","volume":"264","author":"Willett","year":"1994","journal-title":"Science"},{"key":"44","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.tem.2003.09.004","article-title":"Vitamin D and prostate cancer prevention and treatment","volume":"14","author":"Holick","year":"2003","journal-title":"Trends Endocrinol Metab"},{"key":"45","doi-asserted-by":"crossref","first-page":"2050S","DOI":"10.1093\/jn\/135.8.2050S","article-title":"Lycopene effects on rat normal prostate and prostate tumor tissue","volume":"135","author":"Wertz","year":"2005","journal-title":"J Nutr"},{"key":"46","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/jn\/135.2.287","article-title":"Lycopene inhibits the growth of human androgen-independent prostate cancer cells in vitro and in BALB\/c nude mice","volume":"135","author":"Wang","year":"2005","journal-title":"J Nutr"},{"key":"47","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.bcp.2004.05.034","article-title":"Histone deacetylase inhibitors open new doors in cancer therapy","volume":"68","author":"La Thangue","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"48","first-page":"195","article-title":"Urinary excretion of nitrosamino acids and nitrate by inhabitants of high- and low-risk areas for nasopharyngeal carcinoma in southern China","volume":"2","author":"Bartsch","year":"1993","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"49","doi-asserted-by":"crossref","first-page":"634","DOI":"10.2174\/156800908786241050","article-title":"Luteolin, a flavonoid with potential for cancer prevention and therapy","volume":"8","author":"Shen","year":"2008","journal-title":"Curr Cancer Drug Targets"},{"key":"50","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.3390\/molecules13102628","article-title":"Anti-carcinogenic effects of the flavonoid luteolin","volume":"13","author":"Schempp","year":"2008","journal-title":"Molecules"},{"key":"51","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1055\/s-0028-1088314","article-title":"Anti-oxidant, anti-inflammatory and anti-allergic activities of luteolin","volume":"74","author":"Schempp","year":"2008","journal-title":"Planta Med"},{"key":"52","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2174\/138955709787001712","article-title":"Distribution and biological activities of the flavonoid luteolin","volume":"9","author":"Lopez-Lazaro","year":"2009","journal-title":"Mini Rev Med Chem"},{"key":"53","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0304-3835(00)00386-4","article-title":"Inhibitory effect of flavonoids from citrus plants on Epstein-Barr virus activation and two-stage carcinogenesis of skin tumors","volume":"154","author":"Nishino","year":"2000","journal-title":"Cancer Lett"},{"key":"54","doi-asserted-by":"crossref","first-page":"e27915","DOI":"10.1371\/journal.pone.0027915","article-title":"A flavonoid, luteolin, cripples HIV-1 by abrogation of tat function","volume":"6","author":"Chauhan","year":"2011","journal-title":"PLoS One"},{"key":"55","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1248\/bpb.28.253","article-title":"Cytotoxicity of flavonoids toward cultured normal human cells","volume":"28","author":"Kaneko","year":"2005","journal-title":"Biol Pharm Bull"},{"key":"56","doi-asserted-by":"crossref","first-page":"e44810","DOI":"10.1371\/journal.pone.0044810","article-title":"The synergistic effect of chemical carcinogens enhances Epstein-Barr virus reactivation and tumor progression of nasopharyngeal carcinoma cells","volume":"7","author":"Chen","year":"2012","journal-title":"PLoS One"},{"key":"57","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.3390\/ijms16022530","article-title":"EGCG inhibits proliferation, invasiveness and tumor growth by up-regulation of adhesion molecules, suppression of gelatinases activity, and induction of apoptosis in nasopharyngeal carcinoma cells","volume":"16","author":"Chen","year":"2015","journal-title":"Int J Mol Sci"},{"key":"58","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1097\/00007890-199911270-00015","article-title":"Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS\/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting","volume":"68","author":"Bromberg","year":"1999","journal-title":"Transplantation"},{"key":"59","first-page":"204","article-title":"The Epstein-Barr virus in the pathogenesis of posttransplant lymphoproliferative disorders. Clinical, pathologic, and virologic correlation","volume":"90","author":"Najarian","year":"1981","journal-title":"Surgery"},{"key":"60","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/00000658-196809000-00010","article-title":"Five years' experience in renal transplantation with immunosuppressive drugs: survival, function, complications, and the role of lymphocyte depletion by thoracic duct fistula","volume":"168","author":"Harrison","year":"1968","journal-title":"Ann Surg"},{"key":"61","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00007890-196908000-00033","article-title":"Primary malignancy in patients undergoing immunosuppression for renal transplantation","volume":"8","author":"McKhann","year":"1969","journal-title":"Transplantation"},{"key":"62","first-page":"106","article-title":"Malignant lymphomas in transplantation patients","volume":"1","author":"Starzl","year":"1969","journal-title":"Transplant Proc"},{"key":"63","first-page":"107","article-title":"Antibodies to the Epstein-Barr virus in kidney transplant recipients","volume":"191","author":"Andersen","year":"1972","journal-title":"Acta Med Scand"},{"key":"64","first-page":"234","article-title":"Oropharyngeal excretion of Epstein-Barr virus by renal transplant recipients and other patients treated with immunosuppressive drugs","volume":"1","author":"Miller","year":"1974","journal-title":"Lancet"},{"key":"65","doi-asserted-by":"crossref","first-page":"34","DOI":"10.7326\/0003-4819-88-1-34","article-title":"Oropharyngeal excretion of Epstein-Barr virus by patients with lymphoproliferative disorders and by recipients of renal homografts","volume":"88","author":"Neuman","year":"1978","journal-title":"Ann Intern Med"},{"key":"66","first-page":"433","article-title":"Epstein-Barr virus antibody responses and clinical illness in renal transplant recipients","volume":"85","author":"Balfour","year":"1979","journal-title":"Surgery"},{"key":"67","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1097\/00007890-199709270-00010","article-title":"Reduced incidence of Epstein-Barr virus-associated posttransplant lymphoproliferative disorder using preemptive antiviral therapy","volume":"64","author":"Lorber","year":"1997","journal-title":"Transplantation"},{"key":"68","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJM198204153061506","article-title":"Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation","volume":"306","author":"Najarian","year":"1982","journal-title":"N Engl J Med"},{"key":"69","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/ijc.2910280608","article-title":"Studies on long-term T-cell-mediated immunity to Epstein-B arr virus in immunosuppressed renal allograft recipients","volume":"28","author":"Janossy","year":"1981","journal-title":"Int J Cancer"},{"key":"70","first-page":"583","article-title":"Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy","volume":"1","author":"Hardesty","year":"1984","journal-title":"Lancet"},{"key":"71","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1093\/emboj\/19.12.3080","article-title":"The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators","volume":"19","author":"Delecluse","year":"2000","journal-title":"EMBO J"},{"key":"72","doi-asserted-by":"crossref","first-page":"13984","DOI":"10.1128\/JVI.79.22.13984-13992.2005","article-title":"Epstein-Barr virus lytic infection is required for efficient production of the angiogenesis factor vascular endothelial growth factor in lymphoblastoid cell lines","volume":"79","author":"Kenney","year":"2005","journal-title":"J Virol"},{"key":"73","doi-asserted-by":"crossref","first-page":"13993","DOI":"10.1128\/JVI.79.22.13993-14003.2005","article-title":"Epstein-Barr virus lytic infection contributes to lymphoproliferative disease in a SCID mouse model","volume":"79","author":"Kenney","year":"2005","journal-title":"J Virol"},{"key":"74","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1128\/JVI.01512-10","article-title":"A new model of Epstein-Barr virus infection reveals an important role for early lytic viral protein expression in the development of lymphomas","volume":"85","author":"Kenney","year":"2011","journal-title":"J Virol"},{"key":"75","doi-asserted-by":"crossref","first-page":"7976","DOI":"10.1128\/JVI.00770-12","article-title":"An Epstein-Barr virus (EBV) mutant with enhanced BZLF1 expression causes lymphomas with abortive lytic EBV infection in a humanized mouse model","volume":"86","author":"Kenney","year":"2012","journal-title":"J Virol"},{"key":"76","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.cbi.2010.09.020","article-title":"N-methyl-N\u2019-nitro-N-nitrosoguanidine induces and cooperates with 12-O-tetradecanoylphorbol-1,3-acetate\/sodium butyrate to enhance Epstein-Barr virus reactivation and genome instability in nasopharyngeal carcinoma cells","volume":"188","author":"Chen","year":"2010","journal-title":"Chem Biol Interact"},{"key":"77","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1136\/gut.2010.221846","article-title":"Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study","volume":"60","author":"Manesis","year":"2011","journal-title":"Gut"},{"key":"78","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S1473-3099(02)00288-8","article-title":"Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 2: pathogenesis, Castleman's disease, and pleural effusion lymphoma","volume":"2","author":"Seeber","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"79","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1056\/NEJM199506293322604","article-title":"Brief report: treatment of adult T-cell leukemia-lymphoma with zidovudine and interferon alfa","volume":"332","author":"Dreyfus","year":"1995","journal-title":"N Engl J Med"},{"key":"80","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/S0140-6736(00)02879-8","article-title":"Epstein-Barr virus-targeted therapy for AIDS-related primary lymphoma of the central nervous system","volume":"356","author":"Sixbey","year":"2000","journal-title":"Lancet"},{"key":"81","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1182\/blood.V92.5.1721","article-title":"Antisense to the Epstein-Barr virus (EBV)-encoded latent membrane protein 1 (LMP-1) suppresses LMP-1 and bcl-2 expression and promotes apoptosis in EBV-immortalized B cells","volume":"92","author":"Lacy","year":"1998","journal-title":"Blood"},{"key":"82","first-page":"969","article-title":"Switching viral latency to viral lysis: a novel therapeutic approach for Epstein-Barr virus-associated neoplasia","volume":"56","author":"Bhatia","year":"1996","journal-title":"Cancer Res"},{"key":"83","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/978-3-642-56352-2_11","article-title":"Antiviral treatment of Epstein-Barr virus-associated lymphoproliferations","volume":"159","author":"Riess","year":"2002","journal-title":"Recent Results Cancer Res"},{"key":"84","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.bcmd.2006.10.008","article-title":"Short, discontinuous exposure to butyrate effectively sensitizes latently EBV-infected lymphoma cells to nucleoside analogue antiviral agents","volume":"38","author":"Faller","year":"2007","journal-title":"Blood Cells Mol Dis"},{"key":"85","first-page":"5781","article-title":"Activation of lytic Epstein-Barr virus (EBV) infection by radiation and sodium butyrate in vitro and in vivo: a potential method for treating EBV-positive malignancies","volume":"60","author":"Kenney","year":"2000","journal-title":"Cancer Res"},{"key":"86","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1034\/j.1399-3062.2001.003003177.x","article-title":"Epstein-Barr virus post-transplant lymphoproliferative disease and virus-specific therapy: pharmacological reactivation of viral target genes with arginine butyrate","volume":"3","author":"Faller","year":"2001","journal-title":"Transpl Infect Dis"},{"key":"87","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1182\/blood-2006-01-024703","article-title":"A phase 1\/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies","volume":"109","author":"Faller","year":"2007","journal-title":"Blood"},{"key":"88","first-page":"1920","article-title":"Chemotherapy induces lytic EBV replication and confers ganciclovir susceptibility to EBV-positive epithelial cell tumors","volume":"62","author":"Kenney","year":"2002","journal-title":"Cancer Res"},{"key":"89","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1128\/JVI.78.4.1893-1902.2004","article-title":"Lytic induction therapy for Epstein-Barr virus-positive B-cell lymphomas","volume":"78","author":"Kenney","year":"2004","journal-title":"J Virol"},{"key":"90","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1002\/ijc.27439","article-title":"Activation of lytic cycle of Epstein-Barr virus by suberoylanilide hydroxamic acid leads to apoptosis and tumor growth suppression of nasopharyngeal carcinoma","volume":"131","author":"Chiang","year":"2012","journal-title":"Int J Cancer"},{"key":"91","first-page":"639","article-title":"Combination of SAHA and bortezomib up-regulates CDKN2A and CDKN1A and induces apoptosis of Epstein-Barr virus-positive Wp-restricted Burkitt lymphoma and lymphoblastoid cell lines","volume":"167","author":"Chiang","year":"2013","journal-title":"Br J Haematol"},{"key":"92","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1158\/1055-9965.EPI-04-0838","article-title":"Flavonoids and breast cancer risk in Italy","volume":"14","author":"La Vecchia","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"93","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1158\/1055-9965.EPI-06-0017","article-title":"Flavonoids and colorectal cancer in Italy","volume":"15","author":"La Vecchia","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"94","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1080\/01635589809514734","article-title":"Intake of specific carotenoids and flavonoids and the risk of lung cancer in women in Barcelona, Spain","volume":"32","author":"Riboli","year":"1998","journal-title":"Nutr Cancer"},{"key":"95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1207\/s15327914nc5001_1","article-title":"Dietary flavonoids and cancer risk: evidence from human population studies","volume":"50","author":"Neuhouser","year":"2004","journal-title":"Nutr Cancer"},{"key":"96","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.7314\/APJCP.2014.15.14.5501","article-title":"Luteolin, a bioflavonoid inhibits colorectal cancer through modulation of multiple signaling pathways: a review","volume":"15","author":"Esa","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"97","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1093\/jn\/136.3.664","article-title":"Functional diversity of flavonoids in the inhibition of the proinflammatory NF-kappaB, IRF, and Akt signaling pathways in murine intestinal epithelial cells","volume":"136","author":"Haller","year":"2006","journal-title":"J Nutr"},{"key":"98","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/S0006-2952(97)82453-7","article-title":"Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: a comparison with tyrosine kinase and protein kinase C inhibition","volume":"53","author":"Payrastre","year":"1997","journal-title":"Biochem Pharmacol"},{"key":"99","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1196\/annals.1397.102_2","article-title":"Caspase activation and extracellular signal-regulated kinase\/Akt inhibition were involved in luteolin-induced apoptosis in Lewis lung carcinoma cells","volume":"1095","author":"Kim","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"100","doi-asserted-by":"crossref","first-page":"23912","DOI":"10.1074\/jbc.M109.036483","article-title":"Phosphatidylinositol 3-kinase\/Akt pathway targets acetylation of Smad3 through Smad3\/CREB-binding protein interaction: contribution to transforming growth factor beta1-induced Epstein-Barr virus reactivation","volume":"284","author":"Joab","year":"2009","journal-title":"J Biol Chem"},{"key":"101","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1093\/carcin\/bgs364","article-title":"(\u2212)-Epigallocatechin-3-gallate inhibition of Epstein-Barr virus spontaneous lytic infection involves ERK1\/2 and PI3-K\/Akt signaling in EBV-positive cells","volume":"34","author":"Cao","year":"2013","journal-title":"Carcinogenesis"},{"key":"102","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/S0006-291X(03)00067-6","article-title":"Inhibition of Epstein-Barr virus lytic cycle by (\u2212)-epigallocatechin gallate","volume":"301","author":"Liu","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"103","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1248\/bpb.31.2018","article-title":"Inhibition of the Epstein-Barr virus lytic cycle by andrographolide","volume":"31","author":"Liu","year":"2008","journal-title":"Biol Pharm Bull"},{"key":"104","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/mc.10029","article-title":"The chemopreventive compound curcumin is an efficient inhibitor of Epstein-Barr virus BZLF1 transcription in Raji DR-LUC cells","volume":"33","author":"Rosl","year":"2002","journal-title":"Mol Carcinog"},{"key":"105","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.antiviral.2009.12.002","article-title":"Inhibition of the Epstein-Barr virus lytic cycle by moronic acid","volume":"85","author":"Chang","year":"2010","journal-title":"Antiviral Res"},{"key":"106","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/mc.21926","article-title":"Inhibition of Epstein-Barr virus reactivation in nasopharyngeal carcinoma cells by dietary sulforaphane","volume":"52","author":"Chen","year":"2013","journal-title":"Mol Carcinog"},{"key":"107","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0166-0934(91)90006-L","article-title":"Characterization of two monoclonal antibodies to Epstein-Barr virus diffuse early antigen which react to two different epitopes and have different biological function","volume":"33","author":"Glaser","year":"1991","journal-title":"J Virol Methods"},{"key":"108","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF02255596","article-title":"Characterization of monoclonal antibodies to the Zta and DNase proteins of Epstein-Barr virus","volume":"4","author":"Yang","year":"1997","journal-title":"J Biomed Sci"},{"key":"109","doi-asserted-by":"crossref","first-page":"9524","DOI":"10.1073\/pnas.86.23.9524","article-title":"Two epithelial tumor cell lines (HNE-1 and HONE-1) latently infected with Epstein-Barr virus that were derived from nasopharyngeal carcinomas","volume":"86","author":"Li","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"110","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/(SICI)1097-0215(19990924)83:1<121::AID-IJC21>3.0.CO;2-F","article-title":"Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus","volume":"83","author":"Lee","year":"1999","journal-title":"Int J Cancer"},{"key":"111","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1128\/JVI.01602-10","article-title":"Interplay between PKCdelta and Sp1 on histone deacetylase inhibitor-mediated Epstein-Barr virus reactivation","volume":"85","author":"Tsai","year":"2011","journal-title":"J Virol"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.7967","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T19:15:48Z","timestamp":1589224548000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.7967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,8]]},"references-count":111,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2016,4,5]]}},"alternative-id":["7967","26967558"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.7967","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,8]]}}}